Current status of redox markers in immunological and inflammatory diseases

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Overloads of reactive oxygen species (ROS), including superoxide, hydrogen peroxide and hydroxyl radical, that exceed the capacity of antioxidant systems induce oxidative stress in the body. Accumulating evidence suggests that ROS play a critical role in the pathogenesis of immunological and inflammatory diseases. Excessive exposure to ROS is the hallmark of oxidative stress and leads to damage of lipids, proteins and nucleic acids. Recently, specific redox (i.e., reduction/oxidation) biomarkers for oxidative damage and antioxidant defenses have been introduced into the field of clinical and laboratory medicine. This brief review discusses the rapidly accruing data linking oxidative events as critical participants in immunological and inflammatory diseases, including atopic dermatitis, bronchial asthma, systemic inflammatory response syndrome and diabetes mellitus. Data from our recent clinical and experimental studies are presented. Studies evaluating the efficacy of antioxidant substances in the prevention and treatment of the diseases are reviewed, and suggestions are made for the direction of future studies.

Original languageEnglish
Pages (from-to)759-767
Number of pages9
JournalRinsho byori. The Japanese journal of clinical pathology
Volume53
Issue number8
Publication statusPublished - 2005
Externally publishedYes

Fingerprint

Immune System Diseases
Reactive Oxygen Species
Antioxidants
Oxidative Stress
Systemic Inflammatory Response Syndrome
Clinical Medicine
Atopic Dermatitis
Superoxides
Hydroxyl Radical
Nucleic Acids
Hydrogen Peroxide
Diabetes Mellitus
Asthma
Biomarkers
Lipids
Proteins

Cite this

@article{c8d7fb5c7d5546f894166ad7e3b676fd,
title = "Current status of redox markers in immunological and inflammatory diseases",
abstract = "Overloads of reactive oxygen species (ROS), including superoxide, hydrogen peroxide and hydroxyl radical, that exceed the capacity of antioxidant systems induce oxidative stress in the body. Accumulating evidence suggests that ROS play a critical role in the pathogenesis of immunological and inflammatory diseases. Excessive exposure to ROS is the hallmark of oxidative stress and leads to damage of lipids, proteins and nucleic acids. Recently, specific redox (i.e., reduction/oxidation) biomarkers for oxidative damage and antioxidant defenses have been introduced into the field of clinical and laboratory medicine. This brief review discusses the rapidly accruing data linking oxidative events as critical participants in immunological and inflammatory diseases, including atopic dermatitis, bronchial asthma, systemic inflammatory response syndrome and diabetes mellitus. Data from our recent clinical and experimental studies are presented. Studies evaluating the efficacy of antioxidant substances in the prevention and treatment of the diseases are reviewed, and suggestions are made for the direction of future studies.",
author = "Hirokazu Tsukahara",
year = "2005",
language = "English",
volume = "53",
pages = "759--767",
journal = "Rinsho byori. The Japanese journal of clinical pathology",
issn = "0047-1860",
publisher = "Nihon Rinsho Byori Gakkai",
number = "8",

}

TY - JOUR

T1 - Current status of redox markers in immunological and inflammatory diseases

AU - Tsukahara, Hirokazu

PY - 2005

Y1 - 2005

N2 - Overloads of reactive oxygen species (ROS), including superoxide, hydrogen peroxide and hydroxyl radical, that exceed the capacity of antioxidant systems induce oxidative stress in the body. Accumulating evidence suggests that ROS play a critical role in the pathogenesis of immunological and inflammatory diseases. Excessive exposure to ROS is the hallmark of oxidative stress and leads to damage of lipids, proteins and nucleic acids. Recently, specific redox (i.e., reduction/oxidation) biomarkers for oxidative damage and antioxidant defenses have been introduced into the field of clinical and laboratory medicine. This brief review discusses the rapidly accruing data linking oxidative events as critical participants in immunological and inflammatory diseases, including atopic dermatitis, bronchial asthma, systemic inflammatory response syndrome and diabetes mellitus. Data from our recent clinical and experimental studies are presented. Studies evaluating the efficacy of antioxidant substances in the prevention and treatment of the diseases are reviewed, and suggestions are made for the direction of future studies.

AB - Overloads of reactive oxygen species (ROS), including superoxide, hydrogen peroxide and hydroxyl radical, that exceed the capacity of antioxidant systems induce oxidative stress in the body. Accumulating evidence suggests that ROS play a critical role in the pathogenesis of immunological and inflammatory diseases. Excessive exposure to ROS is the hallmark of oxidative stress and leads to damage of lipids, proteins and nucleic acids. Recently, specific redox (i.e., reduction/oxidation) biomarkers for oxidative damage and antioxidant defenses have been introduced into the field of clinical and laboratory medicine. This brief review discusses the rapidly accruing data linking oxidative events as critical participants in immunological and inflammatory diseases, including atopic dermatitis, bronchial asthma, systemic inflammatory response syndrome and diabetes mellitus. Data from our recent clinical and experimental studies are presented. Studies evaluating the efficacy of antioxidant substances in the prevention and treatment of the diseases are reviewed, and suggestions are made for the direction of future studies.

UR - http://www.scopus.com/inward/record.url?scp=32944468805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32944468805&partnerID=8YFLogxK

M3 - Article

C2 - 16190363

AN - SCOPUS:32944468805

VL - 53

SP - 759

EP - 767

JO - Rinsho byori. The Japanese journal of clinical pathology

JF - Rinsho byori. The Japanese journal of clinical pathology

SN - 0047-1860

IS - 8

ER -